- Home
- MBIN vs BBNX Comparison
MBIN vs BBNX Comparison
Compare MBIN & BBNX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | MBIN | BBNX |
|---|---|---|
| Founded | 1990 | 2015 |
| Country | United States | United States |
| Employees | N/A | 409 |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.3B |
| IPO Year | 2017 | 2025 |
Fundamental Metrics
Financial Performance| Metric | MBIN | BBNX |
|---|---|---|
| Price | $36.19 | $29.89 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 3 | 11 |
| Target Price | ★ $39.67 | $28.09 |
| AVG Volume (30 Days) | 148.8K | ★ 672.2K |
| Earning Date | 01-27-2026 | 10-28-2025 |
| Dividend Yield | ★ 1.11% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 4.34 | N/A |
| Revenue | ★ $597,247,000.00 | $88,570,000.00 |
| Revenue This Year | $5.57 | $52.13 |
| Revenue Next Year | $8.80 | $36.16 |
| P/E Ratio | $8.28 | ★ N/A |
| Revenue Growth | N/A | ★ 67.01 |
| 52 Week Low | $27.25 | $8.89 |
| 52 Week High | $43.82 | $32.71 |
Technical Indicators
Market Signals| Indicator | MBIN | BBNX |
|---|---|---|
| Relative Strength Index (RSI) | 75.86 | 57.16 |
| Support Level | $33.88 | $28.00 |
| Resistance Level | $35.59 | $31.51 |
| Average True Range (ATR) | 0.88 | 1.88 |
| MACD | 0.36 | -0.29 |
| Stochastic Oscillator | 99.44 | 40.50 |
Price Performance
Historical ComparisonAbout MBIN Merchants Bancorp
Merchants Bancorp is a United States based bank holding company. It operates multiple lines of business focusing on FHA (Federal Housing Administration) multi-family housing and healthcare facility financing and servicing, retail and correspondent residential mortgage banking, and traditional community banking. The business segments of the company are: Multi-family Mortgage Banking which originates and services government-sponsored mortgages for multi-family and healthcare facilities; Mortgage Warehousing segment which funds agency-eligible residential loans as well as commercial loans to nondepository financial institutions; and the Banking segment, which generates maximum revenue, and provides various financial products and services to consumers and businesses.
About BBNX Beta Bionics Inc.
Beta Bionics Inc is a commercial-stage medical device company engaged in the design, development, and commercialization of solutions to improve the health and quality of life of insulin-requiring people with diabetes (PWD) by utilizing adaptive closed-loop algorithms to simplify and improve the treatment of their disease. The company product includes the iLet Bionic Pancreas (iLet). The Company operates as a single segment, focused on the development, manufacture and sale of the iLet.